This article covers the critical role that laboratory information systems, electronic medical records, and digital imaging plays in patient-centered personalized medicine. The value of integrated diagnostic reports, clinical decision support, and the use of whole-slide imaging to better evaluate cytology samples destined for molecular testing is discussed. This article also highlights the barriers to the widespread adoption ot these disruptive technologies due to regulatory obstacles, limited commercial solutions, poor interoperability, andlack of standardization.